The feud over Ranbaxy patriarch Bhai Mohan Singh's will deepened as Malvinder and Shivender duo (owners of Ranbaxy and Fortis respectively) and Manjit Singh issuing separate notices to the biggest beneficiary, Analjit Singh. The latter had filed for probate of the will on Monday.
While the involved parties declined to comment, sources said the executors of the will have recieved notices but proceedings have not yet been initiated.
Max Group chairman Analjit Singh filed for probate of Bhai Mohan Singh's will in Tis Hazari Court through Delhi-based law firm KR Chawla and Co.
"Besides sending separate notices against the executors they (Malvinder and Shivender and Manjit Singh) will have to initiate proceedings on their own to challenge the case," the sources said.
The two sides (other than Analjit Singh) have hinted that they will move the court.
Bhai Mohan Singh had executed his last will on August 25. It was executed in the presence of Prem Sobti and Vipin Malik.
As per the will, Bhai Mohan Singh is believed to have left behind residential properties in New Delhi's Aurangzeb Road, immovable properties in Chandigarh and Mumbai and shares of over 30 listed and few unlisted companies.
Manjit Singh, Bhai Mohan Singh's second son, has said he would claim his stake in the property held by his parents.
The will gave Analjit Singh rights over 25 lakh shares in Ranbaxy, which have been under litigation.
Do you want to discuss stock tips? Do you know a hot one? Join the Stock Market Investments Discussion Group